tiprankstipranks
Halozyme Therapeutics (HALO)
NASDAQ:HALO

Halozyme (HALO) Technical Analysis

811 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
3Neutral
5Bearish
Technical Analysis Consensus
Sell
2Bullish
3Neutral
5Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Halozyme Therapeutics’s (HALO) Moving Averages Convergence Divergence (MACD) indicator is 1.61, suggesting Halozyme Therapeutics is a Sell.
Halozyme Therapeutics’s (HALO) 20-Day exponential moving average is 42.96, while Halozyme Therapeutics’s (HALO) share price is $44.72, making it a Buy.
Halozyme Therapeutics’s (HALO) 50-Day exponential moving average is 41.12, while Halozyme Therapeutics’s (HALO) share price is $44.72, making it a Buy.

Halozyme (HALO) Pivot Points

May 23, 2024, 02:26 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
44.12
44.41
44.98
45.27
45.84
46.13
46.70
Fibonacci
44.41
44.74
44.94
45.27
45.60
45.80
46.13
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Halozyme (HALO) Moving Averages

May 23, 2024, 02:26 PM
Period
Simple
Exponential
MA5
45.22Buy
45.14Buy
MA10
44.63Buy
44.34Buy
MA20
42.17Buy
42.96Buy
MA50
40.77Buy
41.12Buy
MA100
38.75Buy
39.89Buy
MA200
38.88Buy
39.17Buy
Halozyme Therapeutics’s (HALO) 10-Day exponential moving average is 44.34, while Halozyme Therapeutics’s (HALO) share price is $44.72, making it a Buy.
Halozyme Therapeutics’s (HALO) 100-Day exponential moving average is 39.89, while Halozyme Therapeutics’s (HALO) share price is $44.72, making it a Buy.
Halozyme Therapeutics’s (HALO) stock price is $44.72 and Halozyme Therapeutics’s (HALO) 50-day simple moving average is 40.77, creating a Buy signal.
Halozyme Therapeutics’s (HALO) stock price is $44.72 and Halozyme Therapeutics’s (HALO) 100-day simple moving average is 38.75, creating a Buy signal.
Halozyme Therapeutics’s (HALO) stock price is $44.72 and Halozyme Therapeutics’s (HALO) 200-day simple moving average is 38.88, creating a Buy signal.

Halozyme (HALO) Technical Indicators

May 23, 2024, 02:26 PM
Name
Value
Implied Action
RSI (14)
70.85
Sell
STOCH (9,6)
80.20
Sell
STOCHRSI (14)
88.57
Sell
MACD (12,26)
1.61
Sell
ADX (14)
39.80
Neutral
Williams %R
-10.66
Sell
CCI (14)
90.15
Neutral
ATR (14)
1.24
-
Ultimate Oscillator
52.27
Neutral
ROC
14.21
Buy
Halozyme Therapeutics’s (HALO) Relative Strength Index (RSI) is 70.85, creating a Sell signal.
Halozyme Therapeutics’s (HALO) Trend Strength Indicator (ADX) is 39.80, creating a Neutral signal.
Halozyme Therapeutics’s (HALO) Commodity Channel Index (CCI) is 90.15, creating a Neutral signal.
Halozyme Therapeutics’s (HALO) Price Rate of Change (ROC) is 14.21, creating a Buy signal.

FAQ

Is HALO a Buy, Hold, or Sell?
Based on HALO’s technical indicators, HALO is a Buy.
    What is HALO’s RSI (14)?
    HALO’s RSI (14) is 70.85, which suggests HALO is a Sell.
      What is HALO’s MACD?
      HALO’s MACD is 1.61, which suggests HALO is a Sell.
        What is HALO’s 5-day moving average?
        HALO’s 5-day moving average is 45.22, which suggests HALO is a Buy.
          What is HALO’s 20-day moving average?
          HALO 20-day moving average is 42.17, which suggests HALO is a Buy.
            What is HALO’s 50-day moving average?
            HALO’s 50-day moving average is 40.77, which suggests HALO is a Buy.
              What is HALO’s 200-day moving average?
              HALO’s 200-day moving average is 38.88, which suggests HALO is a Buy.
                What is HALO’s Williams % R (14)?
                HALO’s Williams % R (14) is -10.66, which suggests HALO is a Sell.
                  What is HALO’s CCI (14)?
                  HALO’s CCI (14) is 90.15, which suggests HALO is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis